AGT-100216

N/A

Report date: 2025/06/10 10:17:18
NME

Base Information

Drug NameAGT-100216
Drug Alias NameAGT-100216
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsPeripheral Nervous System DiseasesCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAugustine Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAugustine Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System DiseasesCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A